GPT Healthcare Ratios

GPT Healthcare Ltd Ratios

The GPT Healthcare Ltd Ratios page provides a complete fundamental analysis of GPT Healthcare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking GPT Healthcare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

GPT Healthcare Ltd (NSE: GPTHEALTH, BSE: 544131) is currently trading at ₹124.60, with a market capitalization of ₹10.11B. As a major player in the Health services sector and Hospital/Nursing management industry, GPT Healthcare Ltd remains a key stock for fundamental analysis using GPT Healthcare Ltd Ratios.

GPT Healthcare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The GPT Healthcare Ltd P/E ratio currently stands at 24.11, making it one of the most tracked metrics in GPT Healthcare Ltd Ratios.

Historically, the GPT Healthcare Ltd P/E ratio has shown strong fluctuations:

• 2024: 24.11
• 2023: 29.59
• 2020: 0
• 2019: 0
• 2018: 0

The decline in GPT Healthcare Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The GPT Healthcare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 4.86.

Historical P/B trend:

• 2024: 4.86
• 2023: 6.63
• 2020: 0
• 2019: 0

GPT Healthcare Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The GPT Healthcare Ltd P/S ratio currently stands at 2.96, an important part of GPT Healthcare Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 2.96
• 2023: 3.54
• 2020: 0
• 2019: 0

A stable or declining GPT Healthcare Ltd P/S ratio indicates cautious market sentiment.

GPT Healthcare Ltd Price to Cash Flow Ratio (P/CF)

The GPT Healthcare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 17.

Historical GPT Healthcare Ltd Price to Cash Flow Ratio:

• 2024: 17
• 2023: 20.91
• 2020: 0
• 2019: 0
• 2018: 0

The declining GPT Healthcare Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

GPT Healthcare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The GPT Healthcare Ltd EV currently stands at ₹12B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 12B
• 2023: 14.24B
• 2020: 0
• 2019: 0

GPT Healthcare Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The GPT Healthcare Ltd EV/EBITDA ratio is currently 14.30, a key metric in GPT Healthcare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 14.30
• 2023: 16.07
• 2020: 0
• 2019: 0

Stable GPT Healthcare Ltd EV/EBITDA indicates balanced valuation.

GPT Healthcare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The GPT Healthcare Ltd D/E ratio is currently 0.14, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.14
• 2023: 0.14
• 2020: 0.94
• 2019: 0.92

GPT Healthcare Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The GPT Healthcare Ltd ROE currently stands at 21.41%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 21.41
• 2023: 0
• 2020: 16.18
• 2019: 9.03

GPT Healthcare Ltd demonstrates strong profitability and efficient capital utilization.

GPT Healthcare Ltd Ratios Analysis Summary

The GPT Healthcare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether GPT Healthcare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking GPT Healthcare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.